| Differentiation of mammary tumors and reduction in metastasis upon Malat1 lncRNA loss G Arun, S Diermeier, M Akerman, KC Chang, JE Wilkinson, S Hearn, ... Genes & development 30 (1), 34-51, 2016 | 564 | 2016 |
| CIP2A is a target of bortezomib in human triple negative breast cancer cells LM Tseng, CY Liu, KC Chang, PY Chu, CW Shiau, KF Chen Breast cancer research 14 (2), 1-14, 2012 | 133 | 2012 |
| Novel sorafenib analogues induce apoptosis through SHP-1 dependent STAT3 inactivation in human breast cancer cells CY Liu, LM Tseng, JC Su, KC Chang, PY Chu, WT Tai, CW Shiau, ... Breast Cancer Research 15 (4), 1-14, 2013 | 72 | 2013 |
| MaTAR25 lncRNA regulates the Tensin1 gene to impact breast cancer progression KC Chang, SD Diermeier, AT Yu, LD Brine, S Russo, S Bhatia, H Alsudani, ... Nature communications 11 (1), 1-19, 2020 | 70 | 2020 |
| Mammary Tumor-Associated RNAs Impact Tumor Cell Proliferation, Invasion, and Migration SD Diermeier, KC Chang, SM Freier, J Song, O El Demerdash, A Krasnitz, ... Cell Reports 17 (1), 261-274, 2016 | 64 | 2016 |
| Erratum to: Novel sorafenib analogues induce apoptosis through SHP-1 dependent STAT3 inactivation in human breast cancer cells CY Liu, LM Tseng, JC Su, KC Chang, PY Chu, WT Tai, CW Shiau, ... Breast Cancer Research 19 (1), 1-2, 2017 | 2 | 2017 |
| CIP2A mediates the effect of tamoxifen-induced apoptosis in estrogen receptor negative breast cancer cells. LM Tseng, CY Liu, KC Chang, DS Wang, CW Shiau, KF Chen Cancer Research 73 (8 Supplement), 914-914, 2013 | 2 | 2013 |
| CIP2A mediates the apoptotic effect of bortezomib on triple negative breast cancer cells LM Tseng, CY Liu, KC Chang, CW Shiau, AL Cheng, HY Kuo, CH Tzeng, ... Cancer research 71 (8 Supplement), 2622-2622, 2011 | 2 | 2011 |
| The long non-coding RNA MaTAR20 promotes mammary tumor growth by regulating angiogenesis pathways SD Diermeier, KC Chang, A Frewen, BA Benz, S Russo, D Nowak, ... bioRxiv, 2021 | 1 | 2021 |
| Identification and characterization of long non-coding RNAs as targets of mammary tumor cell proliferation and migration SD Diermeier, KC Chang, SM Freier, J Song, A Krasnitz, F Rigo, ... bioRxiv, 036418, 2016 | 1 | 2016 |
| Methods of treating breast cancer DL Spector, SD Diermeier, F Rigo, CF Bennett, SM Freier, G Arun, ... US Patent 11,058,709, 2021 | | 2021 |
| MaTAR25: a long non-coding RNA involved in breast cancer progression KC Chang, DL Spector Molecular & Cellular Oncology 8 (2), 1882286, 2021 | | 2021 |
| MaTAR25 lncRNA and Its Human Ortholog Regulate the Tensin1 Gene to Impact Breast Cancer Progression KC Chang State University of New York at Stony Brook, 2020 | | 2020 |
| Abstract A43: Long noncoding RNAs as targets of mammary tumor cell proliferation and migration SD Diermeier, KC Chang, SM Freier, F Rigo, CF Bennett, DL Spector Cancer Research 76 (6 Supplement), A43-A43, 2016 | | 2016 |
| Sorafenib analogues SC-1 and SC-43 show better apoptotic effects than sorafenib through SHP-1 dependent STAT3 inhibition in breast cancer cells. CY Liu, LM Tseng, KC Chang, PY Chu, JC Su, WT Tai, CW Shiau, ... Cancer Research 73 (8 Supplement), 3250-3250, 2013 | | 2013 |
| Abstract P6-11-05: Novel sorafenib-derivatives induce apoptosis in breast cancer cells through STAT3 inhibition CY Liu, LM Tseng, KC Chang, PY Chu, JC Su, CW Shiau, KF Chen Cancer Research 72 (24 Supplement), P6-11-05-P6-11-05, 2012 | | 2012 |
| A novel sorafenib-derivative SC-1 induces apoptosis in breast cancer cells through STAT3 inhibition CY Liu, LM Tseng, KC Chang, CW Shiau, JC Su, KF Chen Cancer Research 72 (8 Supplement), 3844-3844, 2012 | | 2012 |
| Anti-tumor effects of SC-2001, a novel STAT3 inhibitor, in breast cancer cells LM Tseng, CY Liu, YP Kao, CW Shiau, JC Su, KC Chang, KF Chen Cancer Research 72 (8 Supplement), 4724-4724, 2012 | | 2012 |
